Comment on: "Safety and Efficacy of Supratarsal Triamcinolone for Treatment of Vernal Keratoconjunctivitis in Ireland"
- PMID: 31725700
- DOI: 10.1097/ICO.0000000000002187
Comment on: "Safety and Efficacy of Supratarsal Triamcinolone for Treatment of Vernal Keratoconjunctivitis in Ireland"
Comment in
-
Reply.Cornea. 2020 Feb;39(2):e5. doi: 10.1097/ICO.0000000000002188. Cornea. 2020. PMID: 31764286 No abstract available.
Comment on
-
Safety and Efficacy of Supratarsal Triamcinolone for Treatment of Vernal Keratoconjunctivitis in Ireland.Cornea. 2019 Aug;38(8):955-958. doi: 10.1097/ICO.0000000000001963. Cornea. 2019. PMID: 31276459
References
-
- McSwiney TJ, Power B, Murphy CC, et al. Safety and efficacy of supratarsal triamcinolone for treatment of vernal keratoconjunctivitis in Ireland. Cornea. 2019;38:955.
-
- Singhal D, Sahay P, Maharana PK, et al. Vernal keratoconjunctivitis. Surv Ophthalmol. 2019;64:289–311.
-
- Chatterjee S, Agrawal D. Tacrolimus in corticosteroid-refractory vernal keratoconjunctivitis. Cornea. 2016;35:1444–1448.
-
- Costa AXD, Gomes JÁP, Marculino LGC, et al. Supratarsal injection of triamcinolone for severe vernal keratoconjunctivitis in children. Arq Bras Oftalmol. 2017;80:186–188.
-
- Holsclaw DS, Whitcher JP, Wong IG, et al. Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis. Am J Ophthalmol. 1996;121:243–249.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
